Current guidelines for treatment of endometriosis. The present status in Japan.

Drugs of today (Barcelona, Spain : 1998) · 2005 · vol. 41 Suppl A , pp. 17–21 · PMID:16200221 · W2414964162
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed
AI-generated summary by claude@2026-06, 2026-06-07

In Japan, laparoscopy is recommended for endometriosis diagnosis and infertility, while GnRH agonists are used for pelvic pain management, especially when preserving reproductive potential.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Laparoscopy currently remains the only effective tool for the diagnosis and evaluation of endometriosis, and in Japan is particularly recommended in patients with concurrent infertility. Diagnosis based on clinical examination alone is associated with a false-negative rate of 19% and a false-positive rate of 44%. Furthermore, unidentified and untreated endometriosis progresses 0.3 revised American Fertility Society (Re-AFS) stage points per month. Given this gradual progression, medical therapy, including long-term treatment, should be initiated in women with definitive evidence of endometriosis who need to maintain their reproductive potential. Gonadotropin- releasing hormone (GnRH) agonists are recommended for the treatment of endometriosis-associated pelvic pain in younger women who wish to become pregnant at a later date, and in women in whom reproductive status is not a concern. Laparoscopy should be used in patients with endometriosis and infertility, while GnRH agonists should be used in patients with pelvic pain.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosisinfertility

MeSH descriptors

Endometriosis Practice Guidelines as Topic Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Humans Japan Laparoscopy Laparoscopy Physical Examination

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0 · commercial use OK